Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Key research presented at this year’s sessions include:

• HEAT-PPCI: Heparin beats bivalirudin in STEMI, amid heated debate
• High-sensitivity hs-troponin again shows promise for MI rule-out
• STAMPEDE: Bariatric surgery clearly better than drugs in obese diabetics
• PCSK9 inhibitors: Presentations generate excitement, overflow crowd
• CORP 2: Colchicine cuts multiple recurrences of pericarditis
• CHOICE: Sapien bests CoreValve for ‘device success’
• MADIT-CRT: CRT survival gains in mild HF durable at seven years
• REGARDS analysis answers critics of new CV-risk equations
• CoreValve High-Risk Study: CoreValve beats high-risk surgery for AV stenosis
• SYMPLICITY HTN-3: End of the road for renal denervation?